EGFRvIII: the promiscuous mutation

por Greenall, Sameer A, Johns, Terrance G
Publicado 2016

Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3

por Greenall, Sameer A., Donoghue, Jacqueline, Johns, Terrance G., Adams, Timothy E.
Publicado 2018

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors

por Endersby, Raelene, Whitehouse, Jacqueline, Hii, Hilary, Greenall, Sameer A., Johns, Terrance G., Gottardo, Nicholas G.
Publicado 2018

Non-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET

por Greenall, Sameer A., Gherardi, Ermanno, Liu, Zhanqi, Donoghue, Jacqueline F., Vitali, Angela A., Li, Qian, Murphy, Roger, Iamele, Luisa, Scott, Andrew M., Johns, Terrance G.
Publicado 2012

Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent Activation

por Ymer, Susie I., Greenall, Sameer A., Cvrljevic, Anna, Cao, Diana X., Donoghue, Jacqui F., Epa, V. Chandana, Scott, Andrew M., Adams, Timothy E., Johns, Terrance G.
Publicado 2011

Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response

por Donoghue, Jacqueline F., Kerr, Lauren T., Alexander, Naomi W., Greenall, Sameer A., Longano, Anthony B., Gottardo, Nicholas G., Wang, Rong, Tabar, Viviane, Adams, Timothy E., Mischel, Paul S., Johns, Terrance G.
Publicado 2018